DexCom (DXCM) PT Raised to $190 at BMO Capital
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.75 -1.89%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BMO Capital analyst Joanne Wuensch raised the price target on DexCom (NASDAQ: DXCM) to $190.00 (from $180.00) while maintaining an Outperform rating.
- story keeps getting better
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
- BMO Capital Reiterates Outperform Rating on Workday (WDAY)
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
